TY  - BOOK
AU  - Thassu,Deepak
AU  - Chader,Gerald
TI  - Ocular Drug Delivery Systems: Barriers and Application of Nanoparticulate Systems 
SN  - 9781439848005 (hardcover : alk. paper)
PY  - 2013///
CY  - Boca Raton
PB  - CRC Press
KW  - Eye Diseases
KW  - drug therapy
KW  - Blood-Retinal Barrier
KW  - Drug delivery systems
KW  - methods
KW  - Nanoparticles
KW  - therapeutic use
N1  - Includes bibliographical references and index; 1; Nanoparticulate-based therapeutics: an overview; Deepak Thassu, Kris Holt, and Gerald J. Chader --; 2; Eye anatomy, physiology and ocular barriers: basic considerations for drug delivery; Gerald J. Chader and Deepak Thassu --; 3; Animal models to evaluate nanoparticulate drug delivery systems; Vinson M. Wang, Jingsheng Tuo, and Chi-Chao Chan --; 4; Computer modeling for ocular drug delivery; Paul J. Missel --; 5; Considerations for development of ophthalmic nanotechnology-based drugs; Banu S. Zolnik, Sherizaq Baksh, and Nakissa Sadrieh --; 6; Blood-retinal barrier: the fundamentals; Rosa Fernandes, Andreia Gon{u386C}ves, and JosCunha-Vaz --; 7; Barriers to transscleral drug delivery to the retina; Alexandra Almazan ... [et al.] --; 8; Drug delivery to the vitreous humor; Francine Behar-Cohen --; 9; Transscleral and suprachoroidal drug delivery; Damian E. Berezovsky and Henry Edelhauser --; 10; Protein drug delivery to retina and choroid; Hogwen M. Rivers and Patrick M. Hughes --; 11; Transscleral drug delivery to the posterior segment of the eye; Bernard F. Godley ... [et al.] --; 12; Drug delivery to the suprachoroidal space; Sung Won Cho and Timothy Olsen --; 13; Use of nanoparticles in the treatment of age-related macular degeneration, glaucoma and other degenerative retinal diseases; Marco A. Zarbin ... [et al.] --; 14; Drug molecule characteristics and their impact on anterior versus posterior segment drug delivery strategies; Kay D. Rittenhouse --; 15; Surface modulation of nanoparticles; Deepak Thassu and Kris Holt --; 16; Nanoparticles for the treatment of retinal diseases / Amin Famili and Uday B. Kompella --; 17; Gene-based medicine for ocular diseases; Shannon M. Conley and Muna I. Naash --; 18; Stealth-type polymeric nanoparticles with encapsulated betamethasone phosphate for treatment of intraocular inflammation; Tsutomu Sakai, Tsutomu Ishihara, and Megumu Higaki --; 19; Nanotechnology-guided imaging of retinal vascular disease; Joshua R. Trantum, John S. Penn, and Ashwath Jayagopal --; 20; Photoresponsive polymers for ocular drug delivery; Laura A. Wells and Heather Sheardown --; t21; Nanosuspensions in ocular drug delivery systems; Himanshu Bhattacharjee and Sonia Bedi
ER  -